We founded Sixfold to tackle the biggest challenge in healthcare: how to safely deliver RNA to diseased cells. We saw the huge potential of RNA therapies being limited to how safely and effectively they can be systemically delivered in people. Our scientists are creative and iterate fast because they want to see what they do in the lab make a difference in the clinic.